Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision label changed from v3.6.5 to v3.6.6, representing a minor update to the page’s documentation/version. No substantive content changes to the study details are indicated.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a funding source entry: 2017 ( U.S. NIH Grant/Contract ). This indicates NIH funding associated with the study.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the study page. There are no indicated changes to the study details in this update.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, reflecting a minor page update. No study content or data has changed.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page's revision tag was updated to v3.6.3, indicating a new documentation revision; the change does not alter substantive study content.SummaryDifference0.0%

- Check91 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new user-facing sections were added: How to Read a Study Record, Common Questions, and How to Join a Study. The Interventions label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and revision metadata changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.